ImmunityBio, Inc.IBRXNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank25
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-351.40M
↓ 30% vs avg
Percentile
P25
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-271.26M
Historical baseline
PeriodValueYoY Change
TTM$-351.40M+15.0%
2024$-413.56M+29.1%
2023$-583.20M-40.0%
2022$-416.57M-20.1%
2021$-346.79M-56.3%
2020$-221.85M-237.2%
2019$-65.79M+31.6%
2018$-96.23M+0.2%
2017$-96.42M+20.2%
2016$-120.81M-